200 related articles for article (PubMed ID: 22223087)
1. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
[TBL] [Abstract][Full Text] [Related]
2. TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency.
Krause K; Eszlinger M; Gimm O; Karger S; Engelhardt C; Dralle H; Fuhrer D
J Clin Endocrinol Metab; 2008 Apr; 93(4):1390-3. PubMed ID: 18198227
[TBL] [Abstract][Full Text] [Related]
3. IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?
Lupo M; Guttler R; Geck Z; Tonozzi TR; Kammesheidt A; Braunstein GD
Endocr Pract; 2018 May; 24(5):453-459. PubMed ID: 29498908
[TBL] [Abstract][Full Text] [Related]
4. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
Eszlinger M; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
[TBL] [Abstract][Full Text] [Related]
5. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
Takano T; Yamada H
Endocr J; 2009; 56(1):9-16. PubMed ID: 18506086
[TBL] [Abstract][Full Text] [Related]
6. [Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].
Takano T
Rinsho Byori; 2012 Feb; 60(2):132-8. PubMed ID: 22568094
[TBL] [Abstract][Full Text] [Related]
7. Value of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in an endemic goitre area.
Mikosch P; Gallowitsch HJ; Kresnik E; Jester J; Würtz FG; Kerschbaumer K; Unterweger O; Dinges HP; Lind P
Eur J Nucl Med; 2000 Jan; 27(1):62-9. PubMed ID: 10654149
[TBL] [Abstract][Full Text] [Related]
8. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.
Bizzarro T; Martini M; Marrocco C; D'Amato D; Traini E; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM; Rossi ED
PLoS One; 2015; 10(7):e0132939. PubMed ID: 26186733
[TBL] [Abstract][Full Text] [Related]
9. ROLE OF MOLECULAR MARKERS IN THYROID NODULE MANAGEMENT: THEN AND NOW.
Nikiforov YE
Endocr Pract; 2017 Aug; 23(8):979-988. PubMed ID: 28534687
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a thyroid nodule.
Bomeli SR; LeBeau SO; Ferris RL
Otolaryngol Clin North Am; 2010 Apr; 43(2):229-38, vii. PubMed ID: 20510711
[TBL] [Abstract][Full Text] [Related]
11. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
12. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
Miseikyte-Kaubriene E; Ulys A; Trakymas M
Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
[TBL] [Abstract][Full Text] [Related]
13. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase 4 and crystallin α-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology.
Davidov T; Nagar M; Kierson M; Chekmareva M; Chen C; Lu SE; Lin Y; Chernyavsky V; Potdevin L; Arumugam D; Barnard N; Trooskin S
J Surg Res; 2014 Aug; 190(2):565-74. PubMed ID: 24880201
[TBL] [Abstract][Full Text] [Related]
15. PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.
Halászlaki C; Tóbiás B; Balla B; Kósa JP; Horányi J; Bölöny E; Nagy Z; Speer G; Járay B; Székely E; Istók R; Székely T; Putz Z; Dank M; Lakatos P; Takács I
Endocr Pract; 2016 Sep; 22(9):1081-7. PubMed ID: 27214302
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
[TBL] [Abstract][Full Text] [Related]
17. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
18. Measurement of TFF3 mRNA in aspirates from thyroid nodules using mesh filtration: the first clinical trial in 130 cases.
Yamada H; Takano T; Kihara M; Hirokawa M; Yoshida H; Watanabe M; Iwatani Y; Hidaka Y; Miyauchi A
Endocr J; 2012; 59(7):621-30. PubMed ID: 22572548
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples.
Kitano M; Rahbari R; Patterson EE; Steinberg SM; Prasad NB; Wang Y; Zeiger MA; Kebebew E
Thyroid; 2012 Mar; 22(3):285-91. PubMed ID: 22304369
[TBL] [Abstract][Full Text] [Related]
20. Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.
Endo M; Nabhan F; Porter K; Roll K; Shirley LA; Azaryan I; Tonkovich D; Perlick J; Ryan LE; Khawaja R; Meng S; Phay JE; Ringel MD; Sipos JA
Thyroid; 2019 Aug; 29(8):1115-1124. PubMed ID: 31154940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
